APA (7th ed.) Citation

Lin, H., Asche, C., Ren, J., Yong, C., Faller, D., & Seal, B. (2016). PCN184 - Healthcare Cost and Utilization Among U.S. Patients with Relapsed/Refractory Systemic Light Chain Amyloidosis (RRAL). Value in Health, 19(7), A741. https://doi.org/10.1016/j.jval.2016.09.2257

Chicago Style (17th ed.) Citation

Lin, HM, CV Asche, J. Ren, C. Yong, D. Faller, and B. Seal. "PCN184 - Healthcare Cost and Utilization Among U.S. Patients with Relapsed/Refractory Systemic Light Chain Amyloidosis (RRAL)." Value in Health 19, no. 7 (2016): A741. https://doi.org/10.1016/j.jval.2016.09.2257.

MLA (9th ed.) Citation

Lin, HM, et al. "PCN184 - Healthcare Cost and Utilization Among U.S. Patients with Relapsed/Refractory Systemic Light Chain Amyloidosis (RRAL)." Value in Health, vol. 19, no. 7, 2016, p. A741, https://doi.org/10.1016/j.jval.2016.09.2257.